ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

By American College of Cardiology

What's ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research about?

The American College of Cardiology offers select interviews and summaries of cardiology’s most interesting research areas from ACCEL’s renowned library, hosted by ACCEL Editor-in-Chief Alison L. Bailey, MD, FACC, FAACPVR.

Download our free app to listen on your phone

ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research episodes:

05.07.2024
Statin Intolerance, Inclisarin, and the VICTORION-INITIATE Trial
The VICTORION-INIATATE study demonstrated that initiating inclisiran, a highly potent lipid-lowering therapy, upon failure to achieve lipid targets with statins, yielded superior outcomes compared to standard care. This approach facilitated a greater proportion of patients in reaching LDL-C targets...
04.23.2024
ARISE-HF Primary Results: Selective Aldose Reductase Inhibitor For Diabetic Cardiomyopathy
Heart failure is an increasingly recognized complication in chronic diabetes that may be caused by a number of processes including direct effects of hyperglycemia on the heart muscle. So-called diabetic cardiomyopathy may affect up to 20% of people with...
04.16.2024
The Future of Cardiology - Value-Based Care, Private Equity and the Practice Landscape
It's becoming increasingly evident that alongside top-notch clinical expertise, the CV specialist of the future must be surrounded by a multi-talented, diverse team to provide optimal patient care. In addition, it is crucial that the clinician and CV organization...
04.09.2024
EMPACT-MI Results: Empagliflozin After Acute Myocardial Infarction
Patients with acute myocardial infarction are at a high risk of heart failure and death. Despite advances in care and reduction in the rate of recurrent myocardial infarctions, the risk for heart failure continues to be unacceptably high. No...
04.02.2024
From JACC: HFpEF: Practical Guidance for Clinicians
About half of patients with chronic heart failure have an ejection fraction >40%. Therapy for patients in this group has been challenging until recently; few therapies have been effective in improving clinical outcomes in this population. Recently, data from...
03.26.2024
From JACC: Aortic Valve Calcium and the Long-Term Risk of Incident Severe AS
Aortic valve disease is often identified too late before clinicans can provide meaningful prevention. Identifying aortic valve calcium opens the door for potential prevention of progression: a phenotype researchers could build randomized controlled trials around. ...
03.19.2024
From JACC: Low-Density Lipoprotein Cholesterol Testing Following MI Hospitalization Among Medicare Beneficiaries
After a heart attack, it is important to lower cholesterol levels to prevent future heart attacks. Monitoring cholesterol levels on treatment is just as important as monitoring blood pressure levels on treatment to make sure that the medicines are...
03.12.2024
JACC State-of-the-Art Review: Racial and Ethnic Disparities in Perioperative Health Care Among Patients Undergoing Cardiac Surgery
This episode covers a review on disparities in cardiovascular perioperative health care. The writers propose actionable solutions utilizing multidisciplinary perspectives from cardiology, cardiac surgery, cardiothoracic anesthesiology, critical care, medical ethics, and health disparity experts. In this interview,...
03.05.2024
From JACC: National Trends in Coronary Artery Disease Imaging: Associations With Health Care Outcomes and Costs
Cardiac imaging is increasingly used in the workup of coronary artery disease, with growth greatest for CCTA and with falling use of SPECT. Because of the low cost of computed tomography, this growing use of imaging has had only...
02.29.2024
ACCEL Lite: Top Takeaways from the AFib Guidelines
In this interview, José A. Joglar, MD, FACC, and Joseph E. Marine MD, MBA, FACC, discuss the top takeaways from the latest atrial fibrillation (AFib) guideline, which provides new and updated recommendations for preventing and optimally managing AFib. ...
02.27.2024
ACCEL Lite: From JACC: Return-to-Play for Elite Athletes With Genetic Heart Diseases Predisposing to Sudden Cardiac Death
A study provides new data for patients with genetic heart disease (GHD) and exercise recommendations. For decades, those with GHD were excluded from exercise and sports participation. This has led to poor exercise tolerance, increased risk for CAD and...
02.20.2024
AHA Late-Breaker ARTESiA: Apixaban for the Prevention of Stroke in Patients With Subclinical AF
Continuous cardiac monitoring detects brief, asymptomatic, heart rhythm abnormalities in one-third of older individuals and these symptoms are associated with an increased risk of stroke. The ARTESiA trial clearly demonstrates that use of the blood thinner apixaban...
02.15.2024
ACCEL Lite: Behind the ACC 2023 Guideline for Chronic CAD: Conversations and Controversies
The 2023 guideline provides an evidenced-based and patient-centered approach to management of patients with chronic coronary disease, considering social determinants of health and incorporating the principles of shared decision-making and team-based care. In this interview, Kristin Newby, MD, FACC,...
02.13.2024
ACCEL Lite: Top Takeaways from the ACC 2023 Guideline for Chronic CAD for the Practicing Clinician
To improve our understanding of the basic principles in the treatment and management of patients with chronic heart disease, in this interview, Salim S. Virani, MD, PhD, FACC, and Roger S. Blumenthal, MD, FACC, discuss top takeaways from the...
02.06.2024
ACCEL Lite: Management of Worsening Heart Failure with Reduced Ejection Fraction
Patients with worsening heart failure are at an extraordinarily high risk for mortality and readmission. Early identification and optimal management of these patients can significantly improve patient outcomes. Several clinical trials in these patients have shown benefit with various...
01.23.2024
ACCEL Lite: AHA Late-Breaker: SELECT – Semaglutide and CV Outcomes in Patients with Overweight or Obesity Who Do Not Have Diabetes
The SELECT trial extends findings from previous trials, which demonstrated cardiovascular benefit in diabetes mellitus (DM), to those without DM. In this interview, Abraham Lincoff, MD, FACC, and Glenn A. Hirsch MD, MHS, FACC, discuss AHA Late-Breaker: SELECT –...
01.16.2024
ACCEL Lite: From JACC: Managing Patients with Moderate Aortic Stenosis
In this review, authors discuss how multimodality imaging can help to evaluate the left ventricular remodeling response and improve risk stratification in patients with moderate aortic stenosis. In this interview, Jeroen J Bax, MD, PhD, FACC, and...
01.09.2024
ACCEL Lite: Top Takeaways from 2023: General Cardiology with Andrew Kates, MD, FACC
In this interview, Andrew Kates, MD, FACC, and Alison L. Bailey, MD, FACC, discuss the top takeaways in general cardiology from 2023 including ARAMIS, ORBITA-2, and STOP-CA trials. Subscribe on Apple Podcasts | Subscribe on Google...
01.03.2024
ACCEL Lite: Pitavastatin to Prevent Cardiovascular Disease in HIV Infection
While we know that statin treatment reduces the risk of stroke, heart attack and heart deaths in people at moderate-to-high risk, or with high cholesterol, in REPRIEVE statins decreased the risk in those at low-to-moderate risk, and with 'normal'...
12.21.2023
ACCEL Lite: Top Takeaways from 2023: Electrophysiology with DJ Lakkireddy, MD, MBA, FACC
In this interview, Dhanunjaya “DJ” Lakkireddy, MBBS, FACC, and Alison L. Bailey, MD, FACC discuss the top takeaways from 2023 in cardiac electrophysiology including AF and the latest guidelines and ARTESIA and MONITOR-AF studies. Subscribe on...
12.19.2023
ACCEL Lite: Top Takeaways from 2023: Preventive Cardiology with Noel Bairey Merz, MD, FACC
In this interview, Noel Bairey Merz, MD, FACC, and Alison L. Bailey, MD, FACC discuss the top takeaways from 2023 in Preventive Cardiology including the CLEAR-Outcomes, REPRIEVE, and SELECT trials. Subscribe on Apple Podcasts | Subscribe...
12.14.2023
ACCEL Lite: Top Takeaways from 2023: Heart Failure with Clyde Yancy MD, MSc, FACC
In this interview, Clyde Yancy MD, MSc, FACC, and Alison L. Bailey MD, FACC, discuss the Top Takeaways from 2023 in Heart Failure. Dr. Yancy discusses trials including STEP-HFpEF, SELCT and DELIVER. Subscribe on Apple Podcasts...
12.12.2023
ACCEL Lite: Top Takeaways from 2023: CV Imaging with Christopher Kramer, MD, FACC
In this interview, Christopher M. Kramer MD, FACC, and Alison L. Bailey MD FACC, discuss the Top Takeaways from 2023 in CV Imaging. Dr. Kramer discusses the PRECISE trial, AI evolution in imaging and more. Subscribe...
12.05.2023
ACCEL Lite: Top Takeaways from 2023: Interventional Cardiology with Deepak Bhatt, MD, MPH, FACC
In this interview, Deepak Bhatt, MD, FACC, and Alison L. Bailey, MD FACC, discuss Top Takeaways from 2023 in Interventional Cardiology. Dr. Bhatt discusses trials including FIRE, MULTISTARS, and TRILUMINATE. Subscribe on Apple Podcasts | Subscribe on...
11.30.2023
ACCEL Lite: AHA Late-Breaker ORBITA-2: Percutaneous Coronary Intervention for Stable Angina: A Randomized, Placebo-Controlled Trial
ORBITA-2 was designed to test whether stents reduce angina more than a placebo procedure in patients with single or multivessel disease on little or no antianginal medication at 12 weeks of follow up. In this interview, Christopher Rajkumar,...
11.28.2023
ACCEL Lite: From JACC: Risk of Arrhythmic Death in Patients With Nonischemic Cardiomyopathy
Nonischemic cardiomyopathy (NICM) is common and patients are at significant risk for early mortality secondary to ventricular arrhythmias. In this interview, Jonathan Chrispin MD, FACC, and Dhanunjaya “DJ” Lakkireddy MBBS, FACC, discuss Risk of Arrhythmic Death in...
11.21.2023
ACCEL Lite: AHA Late-Breaker SPEC-AI: Screening for Peripartum Cardiomyopathies Using an AI-Enhanced Digital Stethoscope: A Randomized Clinical Trial
Detecting HF (cardiac dysfunction) during pregnancy and shortly after having a baby can be challenging for health care professionals and is often delayed. The use of a device powered by artificial intelligence can assist health care providers in identifying...
11.17.2023
ACCEL Lite: AHA Late-Breaker: DAPA-MI - A Registry-Based Randomized Trial of Dapagliflozin in Patients with Acute Myocardial Infarction Without Diabetes
Results of this trial indicate that dapagliflozin treatment immediately after an acute heart attack reduced adverse cardiovascular and metabolic outcomes. In this interview, Stefan James MD, PhD and Laxmi Mehta MD, FACC, discuss AHA Late-Breaker: DAPA-MI - A Registry-Based...
11.07.2023
ACCEL Lite: Cardiovascular Safety of Testosterone-Replacement Therapy
Testosterone is widely prescribed to aging men but there have been concerns about heart-related safety. The FDA mandated that the makers of testosterone products conduct a trial to determine if these drugs increase the risk of heart attack or...
10.24.2023
ACCEL Lite: ESC Hot Line: ECLS-SHOCK - Venoarterial Membrane Oxygenation in Cardiogenic Shock
Does early ECLS improve survival in patients with AMI and cardiogenic shock? In this interview, Holger Thiele MD and Sidney C. Smith Jr. MD, MACC, discuss ESC Hot Line: ECLS-SHOCK - venoarterial membrane oxygenation in cardiogenic shock. ...
10.17.2023
ESC Hot Line: COP-AF – Colchicine for the Prevention of Perioperative AF After Major Thoracic Surgery
Colchicine did not significantly reduce the incidence of two common cardiovascular complications: Perioperative AF and myocardial injury after non-cardiac surgery (MINS). However, there was an encouraging signal of benefit for colchicine to reduce the incidence of adverse cardiovascular outcomes...
10.10.2023
ESC Hot Line: DIG-META: Digoxin in Heart Failure and Atrial Fibrillation
Contrary to findings from observational studies which are inherently affected by bias, digoxin use in randomised controlled trials (RCTs) did not lead to excess mortality in our meta-analysis of 87 studies. There is evidence that digoxin can reduce heart...
10.03.2023
ESC Hot Line: Long-term Outcomes Following LAAO with a Watchman: Outcomes from the NCDR
The rates of stroke after left atrial appendage occlusion with the Watchman device in real-world clinical practice in the US is relatively low and consistent with those from clinical trials despite the high thromboembolic risk of the patients undergoing...
09.26.2023
ESC Hot Line: STEP HFpEF: Once-Weekly Semaglutide in People with HFpEF and Obesity
Currently no approved therapies exist to target obesity-related heart failure with preserved ejection fraction, a condition increasing in prevalence and associated with high symptom burden. In this interview, Mikhail Kosiborod MD, and Alison L. Bailey MD, FACC, discuss ESC...
09.19.2023
ACCEL Lite: ESC Hot Line: CLEAR Outcomes Total Events Analysis
Results presented at the European Society of Cardiology Congress 2023 further support the long-term use of bempedoic acid in patients at high-risk of cardiovascular events and demonstrate particular benefit in those with diabetes. In this interview, Stephen J. Nicholls...
09.12.2023
ACEL Lite: ESC Late-Breaker: RATE-AF Trial Wearables Study
What is known about the use of wearables and their impact on health outcomes and healthcare use among patients with atrial fibrillation. In this interview, Dipak Kotecha MBChB, PhD and Sidney C. Smith Jr. MD, MACC, discuss “ESC...
09.08.2023
ACCEL Lite: ESC Late-Breaker: INTERASPIRE: An International Survey of Secondary prevention of CVD
In selected countries from each of the six WHO regions, the INTERASPIRE survey is being conducted to provide a unique picture of CHD patients, their cardiometabolic, renal and biomarker status, lifestyle and therapeutic management, and the quality of preventive...
08.22.2023
ACCEL Lite: Contemporary Therapy in PAD That Every Cardiologist Should Know
Understanding, recognizing and effectively treating PAD has the potential to dramatically alter a patient’s life. A patient’s ability to walk, quality of life, and longevity can all be profoundly impacted. In this interview, Sasanka Jayasuriya, MD, FACC,...
08.17.2023
ACCEL Lite: Renal Considerations in the Management of Heart Failure
Cardiorenal syndromes cause fluid retention and venous congestion that, in turn, damages the function of vital organs. Providers should have zero tolerance for excessive fluid retention. Aggressive diuretic treatment seems particularly beneficial in patients who are hospitalized for decompensated...
08.15.2023
ACCEL Lite: Managing MVD in STEMI: What We Know and What We Still Need to Learn!
Patients with heart attacks often have a lifesaving procedure to open up the narrowed or blocked coronary artery responsible for their heart attack. In about 30-50% of these patients, additional blockages or narrowings that did not cause the heart...
08.08.2023
ACCEL Lite: Deep Dive into High Sensitivity Troponins in Evaluation of Acute Chest Pain
In this interview, Michael Kontos, MD, FACC, and John Gorcsan III, MD, FACC discuss High Sensitivity Troponins in Evaluation of Acute Chest Pain. Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL ...
08.01.2023
ACCEL Lite: Optimal Medical Therapy for Tricuspid Regurgitation: An Oxymoron?
As device therapy continues to evolve, there is an emerging opportunity to address tricuspid valve disease in patients who previously were overlooked due to their high surgical risk. Proper patient selection and medical optimization will be critical factors driving...
07.28.2023
ACCEL Lite: Revascularization for Heart Failure
In patients with heart failure, viability tests (special heart scans) allow clinicians to distinguish permanently damaged (scarred) parts of the heart from those that may be hibernating and could recover function. Following decades of use based on this theory,...
07.18.2023
ACCEL Lite: Hypertrophic Cardiomyopathy: Genetics, Natural History, Evolution and Septal Reduction Therapies
HCM is present in 1 in 500 individuals around the world. While most patients with HCM can have a normal lifestyle and longevity, there are important issues regarding family screening, sudden cardiac arrest risk, and therapies. In...
07.11.2023
ACCEL Lite: The Multidisciplinary Heart Team For All: What the Revascularization Guidelines Say, and How To Do It
In this interview, Roxana Mehran MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI, and Richard A. Chazal MD, MACC, discuss The Multidisciplinary Heart Team For All: What the Revascularization Guidelines Say and How To Do It. ...
07.06.2023
ACCEL Lite: Cardiovascular Drug Interactions with Paxlovid (Nirmatrelvir/Ritonavir) in Patients with COVID-19
Millions of people are being prescribed Paxlovid for COVID-19 treatment; many of them are on cardiovascular medications. Paxlovid can have potentially harmful interactions with commonly prescribed cardiovascular medications and hence it is crucial to be aware of them and build...
06.29.2023
ACCEL Lite: Impact of Cardiac Interventions and Diagnostic Tests on Carbon Footprint and Potential Solutions
The U.S. health care sector contributes 8% to 10% of total national greenhouse gas (GHG) emissions. The harmful effects of GHG on overall public health as well as cardiovascular diseases are well documented and have been studied extensively. What...
06.27.2023
ACCEL Lite: Practice-Changing Recommendations from the 2023 Multimodality SIHD AUC
The 2023 Appropriate Use Criteria for Chronic Coronary Disease are easier to navigate and less complex than prior versions. The AUC offer clinicians and patients updated clinical guidance on which tests are warranted and also when testing...
06.20.2023
ACCEL Lite: What Does A Cardiologist Need to Know About Chronic Kidney Disease?
Chronic kidney disease (CKD) is highly prevalent in persons with type 2 diabetes (T2D). Patients with T2D and CKD are at high cardiovascular risk. To diagnose CKD and assess risk requires measuring and monitoring kidney function by both estimated globmerular...
06.13.2023
ACCEL Lite: Help Me Breathe! Differentiating HFpEF From Other Causes of Dyspnea
Shortness of breath may be due to many varied causes of which cardiac causes are important to be identified. Despite good contractile function, the heart may fail to pump properly due to impaired filling pressure leading to shortness of...

What's ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research about?

Download our free app to listen on your phone

ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research episodes:

Statin Intolerance, Inclisarin, and the VICTORION-INITIATE Trial

ARISE-HF Primary Results: Selective Aldose Reductase Inhibitor For Diabetic Cardiomyopathy

The Future of Cardiology - Value-Based Care, Private Equity and the Practice Landscape

EMPACT-MI Results: Empagliflozin After Acute Myocardial Infarction

From JACC: HFpEF: Practical Guidance for Clinicians

From JACC: Aortic Valve Calcium and the Long-Term Risk of Incident Severe AS

From JACC: Low-Density Lipoprotein Cholesterol Testing Following MI Hospitalization Among Medicare Beneficiaries

JACC State-of-the-Art Review: Racial and Ethnic Disparities in Perioperative Health Care Among Patients Undergoing Cardiac Surgery

From JACC: National Trends in Coronary Artery Disease Imaging: Associations With Health Care Outcomes and Costs

ACCEL Lite: Top Takeaways from the AFib Guidelines

ACCEL Lite: From JACC: Return-to-Play for Elite Athletes With Genetic Heart Diseases Predisposing to Sudden Cardiac Death

AHA Late-Breaker ARTESiA: Apixaban for the Prevention of Stroke in Patients With Subclinical AF

ACCEL Lite: Behind the ACC 2023 Guideline for Chronic CAD: Conversations and Controversies

ACCEL Lite: Top Takeaways from the ACC 2023 Guideline for Chronic CAD for the Practicing Clinician

ACCEL Lite: Management of Worsening Heart Failure with Reduced Ejection Fraction

ACCEL Lite: AHA Late-Breaker: SELECT – Semaglutide and CV Outcomes in Patients with Overweight or Obesity Who Do Not Have Diabetes

ACCEL Lite: From JACC: Managing Patients with Moderate Aortic Stenosis

ACCEL Lite: Top Takeaways from 2023: General Cardiology with Andrew Kates, MD, FACC

ACCEL Lite: Pitavastatin to Prevent Cardiovascular Disease in HIV Infection

ACCEL Lite: Top Takeaways from 2023: Electrophysiology with DJ Lakkireddy, MD, MBA, FACC

ACCEL Lite: Top Takeaways from 2023: Preventive Cardiology with Noel Bairey Merz, MD, FACC

ACCEL Lite: Top Takeaways from 2023: Heart Failure with Clyde Yancy MD, MSc, FACC

ACCEL Lite: Top Takeaways from 2023: CV Imaging with Christopher Kramer, MD, FACC

ACCEL Lite: Top Takeaways from 2023: Interventional Cardiology with Deepak Bhatt, MD, MPH, FACC

ACCEL Lite: AHA Late-Breaker ORBITA-2: Percutaneous Coronary Intervention for Stable Angina: A Randomized, Placebo-Controlled Trial

ACCEL Lite: From JACC: Risk of Arrhythmic Death in Patients With Nonischemic Cardiomyopathy

ACCEL Lite: AHA Late-Breaker SPEC-AI: Screening for Peripartum Cardiomyopathies Using an AI-Enhanced Digital Stethoscope: A Randomized Clinical Trial

ACCEL Lite: AHA Late-Breaker: DAPA-MI - A Registry-Based Randomized Trial of Dapagliflozin in Patients with Acute Myocardial Infarction Without Diabetes

ACCEL Lite: Cardiovascular Safety of Testosterone-Replacement Therapy

ACCEL Lite: ESC Hot Line: ECLS-SHOCK - Venoarterial Membrane Oxygenation in Cardiogenic Shock

ESC Hot Line: COP-AF – Colchicine for the Prevention of Perioperative AF After Major Thoracic Surgery

ESC Hot Line: DIG-META: Digoxin in Heart Failure and Atrial Fibrillation

ESC Hot Line: Long-term Outcomes Following LAAO with a Watchman: Outcomes from the NCDR

ESC Hot Line: STEP HFpEF: Once-Weekly Semaglutide in People with HFpEF and Obesity

ACCEL Lite: ESC Hot Line: CLEAR Outcomes Total Events Analysis

ACEL Lite: ESC Late-Breaker: RATE-AF Trial Wearables Study

ACCEL Lite: ESC Late-Breaker: INTERASPIRE: An International Survey of Secondary prevention of CVD

ACCEL Lite: Contemporary Therapy in PAD That Every Cardiologist Should Know

ACCEL Lite: Renal Considerations in the Management of Heart Failure

ACCEL Lite: Managing MVD in STEMI: What We Know and What We Still Need to Learn!

ACCEL Lite: Deep Dive into High Sensitivity Troponins in Evaluation of Acute Chest Pain

ACCEL Lite: Optimal Medical Therapy for Tricuspid Regurgitation: An Oxymoron?

ACCEL Lite: Revascularization for Heart Failure

ACCEL Lite: Hypertrophic Cardiomyopathy: Genetics, Natural History, Evolution and Septal Reduction Therapies

ACCEL Lite: The Multidisciplinary Heart Team For All: What the Revascularization Guidelines Say, and How To Do It

ACCEL Lite: Cardiovascular Drug Interactions with Paxlovid (Nirmatrelvir/Ritonavir) in Patients with COVID-19

ACCEL Lite: Impact of Cardiac Interventions and Diagnostic Tests on Carbon Footprint and Potential Solutions

ACCEL Lite: Practice-Changing Recommendations from the 2023 Multimodality SIHD AUC

ACCEL Lite: What Does A Cardiologist Need to Know About Chronic Kidney Disease?

ACCEL Lite: Help Me Breathe! Differentiating HFpEF From Other Causes of Dyspnea